Océanie · Actualité générale · PerthNow

Cancer vaccine cuts melanoma death risk by 42 per cent

Publié par PerthNow · Australie il y a 1 h

Merck and Moderna have released results of a late-stage trial that showed an experimental mRNA vaccine slashed the risk that melanoma returns by 42 per cent.

Lire l'article complet sur PerthNow Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.perthnow.com.au)

Cancer vaccine cuts melanoma death risk by 42 per cent

À lire aussi

DigiCert Enters FedRAMP Marketplace, Advances Toward 20x Class C Certification

The multimillion-dollar cost of sending the Australian of the Year into space

The multimillion-dollar cost of sending the Australian of the Year into space

The multimillion-dollar cost of sending the Australian of the Year into space

World’s largest battery electric ship starts ferrying passengers – and “it all started in Tasmania”

Australia sanctions North Korean IT worker bosses and financiers

Cancer vaccine cuts melanoma death risk by 42 per cent

Partager

À lire aussi

DigiCert Enters FedRAMP Marketplace, Advances Toward 20x Class C Certification

The multimillion-dollar cost of sending the Australian of the Year into space

The multimillion-dollar cost of sending the Australian of the Year into space

The multimillion-dollar cost of sending the Australian of the Year into space

World’s largest battery electric ship starts ferrying passengers – and “it all started in Tasmania”

Australia sanctions North Korean IT worker bosses and financiers